61 studies found for:    Carcinoembryonic antigen
Show Display Options
Rank Status Study
21 Completed Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Other: pharmacological study;   Procedure: single photon emission computed tomography;   Radiation: iodine I 123 anti-CEA recombinant diabody T84.66
22 Completed Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: yttrium Y 90 monoclonal antibody MN-14
23 Recruiting A Study of RO6895882 in Patients With Advanced and/or Metastatic Solid Tumors
Condition: Neoplasms
Intervention: Drug: RO6895882
24 Completed Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: CEA peptide 1-6D
25 Unknown  Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
Condition: Circulating Tumor Cells
26 Completed Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed
Condition: Colorectal Cancer
Interventions: Drug: fluorouracil;   Drug: leucovorin calcium;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
27 Completed Immune Response in Peripheral Blood of Patients With Colon Cancer
Condition: Colorectal Cancer
Interventions: Other: immunoenzyme technique;   Other: laboratory biomarker analysis
28 Active, not recruiting Tecemotide (L-BLP25) in Rectal Cancer
Condition: Rectal Cancer
Interventions: Other: Chemoradiation Therapy;   Drug: Cyclophosphamide (CPA);   Other: Biological: Tecemotide (L-BLP25)
29 Unknown  Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: floxuridine;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin
30 Unknown  Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer
Condition: Rectal Cancer
Interventions: Radiation: radiation therapy;   Drug: capecitabine (625mg/m2,bid,d1-5 qw)and oxaliplatin (85mg/m2 d1 qw)
31 Recruiting PET-CT and Circulating Tumor Cells in Colorectal Cancer
Conditions: Colorectal Cancer;   Metastasis
Intervention: Drug: Chemotherapy
32 Completed Enzastaurin for Patients With Metastatic Colorectal Cancer
Condition: Colonic Neoplasms
Intervention: Drug: Enzastaurin HCl
33 Recruiting A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas
Condition: Gastrointestinal Adenocarcinomas
Intervention: Drug: MEDI-565
34 Recruiting Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Other: Blood sampling
35 Terminated For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy
Conditions: Neoplasm Metastasis;   Colorectal Neoplasms
Interventions: Drug: Celecoxib;   Drug: Irinotecan;   Drug: 5-fluorouracil;   Drug: Leucovorin
36 Recruiting A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
Condition: Metastatic Biliary Tract Carcinoma
Intervention: Drug: Regorafenib
37 Completed Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Other: laboratory biomarker analysis;   Procedure: cryosurgery;   Procedure: radiofrequency ablation;   Procedure: therapeutic conventional surgery
38 Completed Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus NV1020 to Treat Colorectal Cancer Metastatic to Liver
Conditions: Colorectal Cancer;   Liver Neoplasms
Intervention: Drug: NV1020
39 Completed New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
Condition: Gallbladder Neoplasms
Interventions: Drug: Somatostatin;   Drug: epirubicin, cisplatin, LV(Leucovorin)、 5-FU(5-Fluorouracil)
40 Recruiting Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: EGFRBi-armed autologous activated T cells;   Biological: aldesleukin;   Biological: sargramostim

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years